Carisma Therapeutics Inc (NASDAQ: CARM) is 165.04% higher on its value in year-to-date trading and has touched a low of $0.14 and a high of $1.90 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CARM stock was last observed hovering at around $0.23 in the last trading session, with the day’s gains setting it 0.88%.
Currently trading at $1.11, the stock is 373.52% and 405.06% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 692.32 million and changing 389.42% at the moment leaves the stock 88.30% off its SMA200. CARM registered 0.00% loss for a year compared to 6-month loss of 40.15%. The firm has a 50-day simple moving average (SMA 50) of $0.21982 and a 200-day simple moving average (SMA200) of $0.58955.
The stock witnessed a 482.68% gain in the last 1 month and extending the period to 3 months gives it a 139.22%, and is 524.65% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 75.35% over the week and 35.95% over the month.
Carisma Therapeutics Inc (CARM) has around 46 employees, a market worth around $46.40M and $19.96M in sales. Profit margin for the company is -254.28%. Distance from 52-week low is 683.35% and -41.58% from its 52-week high.
with sales reaching $3.75M over the same period.The EPS is expected to grow by 50.00% this year, but quarterly earnings will post -23.59% year-over-year. Quarterly sales are estimated to shrink -59.23% in year-over-year returns.
Carisma Therapeutics Inc (CARM) Top Institutional Holders
45.0 institutions hold shares in Carisma Therapeutics Inc (CARM), with institutional investors hold 43.96% of the company’s shares. The shares outstanding are 41.79M, and float is at 21.12M with Short Float at 3.98%. Institutions hold 31.76% of the Float.
The top institutional shareholder in the company is VANGUARD GROUP INC with over 1.45 million shares valued at $2.2 million. The investor’s holdings represent 3.4861% of the CARM Shares outstanding. As of 2024-06-30, the second largest holder is TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA with 1.25 million shares valued at $1.9 million to account for 3.014 of the shares outstanding. The other top investors are TPG GP A, LLC which holds 0.84 million shares representing 2.0269% and valued at over $1.28 million, while BLACKROCK INC. holds 1.7091 of the shares totaling 0.71 million with a market value of $1.08 million.
Carisma Therapeutics Inc (CARM) Insider Activity
#####
